Prevalence of potential drug–drug interactions in bone marrow transplant patients (2011)
Fonte: International Journal of Clinical Pharmacy. Unidade: EE
Assuntos: MEDICAMENTO (INTERAÇÃO;PREVALÊNCIA), TRANSPLANTES
ABNT
GUASTALDI, Rosimeire Barbosa Fonseca et al. Prevalence of potential drug–drug interactions in bone marrow transplant patients. International Journal of Clinical Pharmacy, v. 33, n. 6, p. 1002-1009, 2011Tradução . . Disponível em: https://doi.org/10.1007/s11096-011-9574-2. Acesso em: 22 ago. 2024.APA
Guastaldi, R. B. F., Reis, A. M. M., Figueiras, A., & Secoli, S. R. (2011). Prevalence of potential drug–drug interactions in bone marrow transplant patients. International Journal of Clinical Pharmacy, 33( 6), 1002-1009. doi:10.1007/s11096-011-9574-2NLM
Guastaldi RBF, Reis AMM, Figueiras A, Secoli SR. Prevalence of potential drug–drug interactions in bone marrow transplant patients [Internet]. International Journal of Clinical Pharmacy. 2011 ; 33( 6): 1002-1009.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1007/s11096-011-9574-2Vancouver
Guastaldi RBF, Reis AMM, Figueiras A, Secoli SR. Prevalence of potential drug–drug interactions in bone marrow transplant patients [Internet]. International Journal of Clinical Pharmacy. 2011 ; 33( 6): 1002-1009.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1007/s11096-011-9574-2